Skip to main content
SpringerLink
Log in
Book cover

Hughes Syndrome pp 415–426Cite as

Interaction of Antiphospholipid Antibodies with Endothelial Cells

  • Chapter

  • 732 Accesses

Keywords

  • Systemic Lupus Erythematosus
  • Lupus Anticoagulant
  • Endothelial Cell Monolayer
  • Soluble Adhesion Molecule
  • Human Umbilical Cord Vein Endothelial Cell

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference List

  1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752–763.

    CrossRef  PubMed  CAS  Google Scholar 

  2. Meroni PL, Riboldi P. Pathogenic mechanisms mediating antiphospholipid syndrome. Curr Opin Rheumatol 2001;13:377–382.

    CrossRef  PubMed  CAS  Google Scholar 

  3. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527–3561.

    PubMed  CAS  Google Scholar 

  4. Carreras LO, Vermylen JG. Lupus anticoagulant and thrombosis: possible role of inhibition of prostacyclin formation. Thromb Haemost 1992;48:38–40.

    Google Scholar 

  5. Del Papa N, Guidali L, Spatola L, et al. Relationship between anti-phospholipid and anti-endothelial antibodies III: β2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995;13:179–186.

    PubMed  Google Scholar 

  6. Simantov R, LaSala JM, Lo SK, et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995;96:2211–2219.

    PubMed  CAS  Google Scholar 

  7. Le Tonqueze M, Salozhin K, Dueymes M, et al. Role of β2-glycoprotein I in the anti-phospholipid antibody binding to endothelial cells. Lupus 1995;4:179–186.

    PubMed  Google Scholar 

  8. Del Papa N, Guidali L, Sala A, et al. Endothelial cell as target for antiphospholipid antibodies. Arthritis Rheum 1997;40:551–561.

    PubMed  Google Scholar 

  9. Del Papa N, Sheng YH, Raschi E, et al. Human β2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-β2-glycoprotein I antibodies. J Immunol 1998;160:5572–5578.

    PubMed  Google Scholar 

  10. George J, Blank M, Levy Y, et al. Differential effects of anti-beta 2 glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 1998;97:900–906.

    PubMed  CAS  Google Scholar 

  11. Cho CS, Cho ML, Chen PP, et al. Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells. J Immunol 2002;168:4209–4215.

    PubMed  CAS  Google Scholar 

  12. Hasselaar P, Derksen RH, Oosting JD, et al. Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on expression of procoagulant activity by cultured endothelial cells. Thromb Haemost 1989;62:654–660.

    PubMed  CAS  Google Scholar 

  13. Branch DW, Rodgers G. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. Am J Obstet Gynecol 1993;168:206–210.

    PubMed  CAS  Google Scholar 

  14. Kornberg A, Renaudineau Y, Blank M, et al. Anti-beta 2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells. Isr Med Assoc J 2000;2(suppl):27–31.

    PubMed  Google Scholar 

  15. Ferrara DE, Swerlick R, Casper K, et al. Fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. Thromb Haemost 2004. In press.

    Google Scholar 

  16. Marciniak E, Romond EH. Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant. Blood 1989;74:2426–2432.

    PubMed  CAS  Google Scholar 

  17. Ruiz-Arguelles GJ, Ruiz-Arguelles A, Deleze M, et al. Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin. J Rheumatol 1989;16:381–383.

    PubMed  CAS  Google Scholar 

  18. Ieko M, Sawada KI, Koike T, et al. The putative mechanism of thrombosis in antiphospholipid syndrome: impairment of the protein C and the fibrinolytic systems by monoclonal anticardiolipin antibodies. Semin Thromb Hemost 1999;25:503–507.

    PubMed  CAS  Google Scholar 

  19. de Groot PG, Derksen RHWM. The influence of antiphospholipid antibodies on the protein C pathway. In: Khamashta MA, ed. Hughes syndrome, antiphospholipid syndrome. London: Springer; 2000:307–316.

    Google Scholar 

  20. Esmon NL, Safa O, Smirnov MD, et al. Antiphospholipid antibodies and the protein C. J Autoimmun 2000;15:221–225.

    CrossRef  PubMed  CAS  Google Scholar 

  21. Rand JH. Molecular pathogenesis of the antiphospholipid syndrome. Circ Res 2002;90:29–37.

    CrossRef  PubMed  CAS  Google Scholar 

  22. Atsumi T, Khamashta MA, Haworth RS, et al. Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1. Arthritis Rheum 1998;41:800–807.

    CrossRef  PubMed  CAS  Google Scholar 

  23. Nakamura N, Ban T, Yamaji K, et al. Lupus anticoagulant autoantibody induces apoptosis in HUVEC: involvement of annexin V. Biochem Byophys Res Commun 1994;205:1488–1493.

    CrossRef  CAS  Google Scholar 

  24. Galve-de Rochemonteix B, Kobayashi T, Rosnoblet C, et al. Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells. Arterioscler Thromb Vasc Biol 2000;20:563–574.

    PubMed  CAS  Google Scholar 

  25. Pierangeli SS, Gharavi AE, Harris N. Experimental thrombosis and antiphospholipid antibodies: new insights. J Autoimmun 2000;15:241–247.

    CrossRef  PubMed  CAS  Google Scholar 

  26. Espinola RG, Liu X, Colden-Stanfield M, et al. E-Selectin mediates pathogenic effects of antiphospholipid antibodies. J Thromb Haemost 2003;1:843–848.

    CrossRef  PubMed  CAS  Google Scholar 

  27. Vismara A, Meroni PL, Tincani A, et al. Antiphospholipid antibodies and endothelial cells. Clin Exp Immunol 1988;74:247–253.

    PubMed  CAS  Google Scholar 

  28. Hasselaar P, Derksen RH, Blokzijl L, et al. Cross-reactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost 1990;63:69–173.

    Google Scholar 

  29. Le Roux G, Wautier MP, Guillevin L, et al. IgG binding to endothelial cells in systemic lupus erythematosus. Thromb Haemost 1986;56:144–146.

    PubMed  Google Scholar 

  30. Rosenbaum J, Pottinger BE, Woo P, et al. Measurement and characterization of circulating antiendothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1998;72:450–456.

    Google Scholar 

  31. McCrae KR, DeMichele A, Samuels P, et al. Detection of endothelial cell reactive immunoglobulin in patients with anti-phospholipid antibodies. Br J Haematol 1991;79:595–605.

    PubMed  CAS  Google Scholar 

  32. Del Papa N, Meroni PL, Tincani A, et al. Relationship between antiphospholipid and antiendothelial antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol 1992;10:37–42.

    PubMed  Google Scholar 

  33. Del Papa N, Conforti G, Gambini D, et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1994;70:211–216.

    CrossRef  PubMed  Google Scholar 

  34. Tincani A, Spatola L, Prati E, et al. The anti-β2 glycoprotein I activity in human antiphospholipid syndrome sera is due to monoreactivity low-affinity autoantibodies directed to epitopes located on native β2 glycoprotein I and preserved during species’ evolution. J Immunol 1996;157:5732–5738.

    PubMed  CAS  Google Scholar 

  35. Meroni PL, Tincani A, Sepp N, et al. Endothelium and the brain in CNS lupus. Lupus 2003;12:919–928.

    CrossRef  PubMed  CAS  Google Scholar 

  36. Revelen R, Bordron A, Dueymes M, et al. False positivity in a cyto-ELISA for anti-endothelial cell antibodies caused by heterophile antibodies to bovine serum proteins. Clin Chemistry 2000;46:273–278.

    CAS  Google Scholar 

  37. Harper L, Savage CO. Anti-heparin antibodies: part of the repertoire of anti-endothelial cell antibodies (AECA). Lupus 1998;7:68–72.

    CrossRef  PubMed  CAS  Google Scholar 

  38. Cai G, Satoh T, Hoshi H. Purification and characterization of an endothelial cell-viability maintaining factor from fetal bovine serum. Biochim Biophys Acta 1995;1269:13–18.

    CrossRef  PubMed  Google Scholar 

  39. Moestrup SK, Schousboe I, Jacobsen C, et al. β2-glycoprotein-I (apolipoprotein H) and β2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin. J Clin Invest 1998;102:902–909.

    PubMed  CAS  Google Scholar 

  40. Cao W, Atsumi T, Yamashita Y, et al. A possible binding of β2-glycoprotein I to megaline, an endocytic receptor on trophoblast. J Autoimmun 2000;15:A61.

    CrossRef  Google Scholar 

  41. Lutters BC, Derksen RH, Tekelenburg WL, et al. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2’. J Biol Chem 2003;278:33831–33838.

    CrossRef  PubMed  CAS  Google Scholar 

  42. Sacre SM, Standard AK, Owen JS. Apolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cells. FEBS Lett 2003;540:181–187.

    CrossRef  PubMed  CAS  Google Scholar 

  43. Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 1994;269:21198–21203.

    PubMed  CAS  Google Scholar 

  44. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 1994;269:21191–21197.

    PubMed  CAS  Google Scholar 

  45. Hajjar KA, Mauri L, Jacovina AT, et al. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine. J Biol Chem 1998;273:9987–9993.

    CrossRef  PubMed  CAS  Google Scholar 

  46. Ma K, Simantov R, Zhang JC, et al. High affinity binding of β2-glycoprotein I to human endothelial cells is mediated by Annexin II. J Biol Chem 2000;20:15541–15548.

    CrossRef  Google Scholar 

  47. Caronti B, Calderaro C, Alessandri C, et al. Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage. Clin Exp Immunol 1999;115:214–219.

    CrossRef  PubMed  CAS  Google Scholar 

  48. Alvarado-de la Barrera C, Bahena S, Llorente L, et al. Beta2-glycoprotein-I mRNA transcripts are expressed by hepatocytes but not by resting or activated human endothelial cells. Thromb Res 1998;90:239–243.

    CrossRef  PubMed  CAS  Google Scholar 

  49. George J, Harats D, Gilburd B, et al. Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation 1999;99:2227–2230.

    PubMed  CAS  Google Scholar 

  50. Nawrot P, Stern D. Endothelial cell procoagulant properties and the host response. Semin Thromb Hemost 1987;13:391–398.

    CrossRef  Google Scholar 

  51. Carlos TM, Harlam JM. Leukocyte-endothelial adhesion molecule. Blood 1994;84:2068–2101.

    PubMed  CAS  Google Scholar 

  52. Pierangeli SS, Espinola RG, Liu X, et al. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular adhesion molecule-1, and P-selectin. Circ Res 2001;88:245–250.

    PubMed  CAS  Google Scholar 

  53. Jankowski M, Vreys I, Wittevrongel C, et al. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood 2003;101:157–162.

    CrossRef  PubMed  CAS  Google Scholar 

  54. Ferro D, Pittoni V, Quintarelli C, et al. Coexistence of anti-phospholipid antibodies and endothelial perturbation in systemic lupus erythematosus patients with ongoing prothrombotic state. Arthritis Rheum 1997;95:1425–1432.

    CAS  Google Scholar 

  55. Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999;104:93–102.

    CrossRef  PubMed  CAS  Google Scholar 

  56. Kaplanski G, Cacoub P, Farnarier C, et al. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis. Arthritis Rheum 2000;43:55–64.

    CrossRef  PubMed  CAS  Google Scholar 

  57. Williams FMK, Parmar K, Hughes GRV, et al. Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemost 2000;84:742–746.

    PubMed  CAS  Google Scholar 

  58. Frijns CJM, Derksen RHWM, De Groot PG, et al. Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus. Clin Exp Immunol 2001;125:149–154.

    CrossRef  PubMed  CAS  Google Scholar 

  59. Afek A, Shoenfeld Y, Manor R, et al. Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome. Lupus 1999;8:502–507.

    CrossRef  PubMed  CAS  Google Scholar 

  60. Boffa MC, Karmochkine M. Thrombomodulin: an overview and potential implications in vascular disorders. Lupus 1998;7(suppl 2):S120–S125.

    CrossRef  PubMed  CAS  Google Scholar 

  61. Raitakari OT, Celermajer DS. Testing for endothelial dysfunctiom. Ann Med 2000;32:293–304.

    PubMed  CAS  Google Scholar 

  62. Dignat-Gorge F, Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 2000;65:215–220.

    CrossRef  Google Scholar 

  63. Faulx MD, Wright AT, Hoit BD. Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J 2003;145:943–951.

    CrossRef  PubMed  Google Scholar 

  64. Meroni PL, Raschi E, Testoni C, et al. Statins prevent endothelial cell activation induced by antiphospholipid (anti-β2 glycoprotein I) antibodies. Arthritis Rheum 2001;44:2870–2878.

    CrossRef  PubMed  CAS  Google Scholar 

  65. Dunoyer-Geindre S, de Moerloose P, Galve-de Rochemonteix B, et al. NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies. Thromb Haemost 2002;88:851–857.

    PubMed  Google Scholar 

  66. Pierangeli SS, Vega-Ostertag M, Harris EN. Intracellular signaling triggered by antiphospholipid Antibodies in platelets and endothelial cells: a pathway to targeted therapies. Thromb Res 2004. In press.

    Google Scholar 

  67. Raschi E, Testoni C, Bosisio D, et al. Role of the MyD88 transduction signaling pathway in endothelial activation by anti-phospholipid antibodies. Blood 2003;101:3495–3500.

    CrossRef  PubMed  CAS  Google Scholar 

  68. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135–145.

    CrossRef  PubMed  CAS  Google Scholar 

  69. Lien E, Ingalls RR. Toll-like receptors. Crit Care Med 2002;30:S1–S11.

    CrossRef  CAS  Google Scholar 

  70. Gharavi AE, Pierangeli SS, Colden-Stanfield M, et al. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro. J Immunol 1999;163:2922–2927.

    PubMed  CAS  Google Scholar 

  71. Blank M, Krause I, Fridkin M, et al. Bacterial induction of autoantibodies to β2-glycoprotein-1 accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002;109:797–804.

    CrossRef  PubMed  CAS  Google Scholar 

  72. Blank M, Asherson RA, Cervera R, et al. Antiphospholipid syndrome infectious origin. J Clin Immunol 2004;24:12–23.

    CrossRef  PubMed  CAS  Google Scholar 

  73. George J, Haratz D, Shoenfeld Y. Accelerated atheroma, antiphospholipid antibodies, and the antiphospholipid syndrome. Rheum Dis Clin North Am 2001;27:603–610.

    CrossRef  PubMed  CAS  Google Scholar 

  74. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999;340:115–126.

    CrossRef  PubMed  CAS  Google Scholar 

  75. Xu XH, Shah PK, Faure E, et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001;104:3103–3108.

    PubMed  CAS  Google Scholar 

  76. Edfeldt K, Swedenborg J, Hansson GK, et al. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 2002;105:1158–1161.

    PubMed  CAS  Google Scholar 

  77. Ferrara DE, Liu X, Espinola RG, et al. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model. Arthritis Rheum 2003;48:3272–3279.

    CrossRef  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, IRCCS Istituto Auxologico Italiano, University of Milan, Milan, Italy

    Pier Luigi Meroni MD, Elena Raschi PhD, Cinzia Testoni PhD, Arianna Parisio PhD, Maria Gerosa MD & Maria Orietta Borghi PhD

Authors
  1. Pier Luigi Meroni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena Raschi PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cinzia Testoni PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arianna Parisio PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Gerosa MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maria Orietta Borghi PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lupus Research Unit, St Thomas’ Hospital, London, UK

    M. A. Khamashta MD, FRCP, PhD (Deputy Head) (Deputy Head)

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Meroni, P.L., Raschi, E., Testoni, C., Parisio, A., Gerosa, M., Borghi, M.O. (2006). Interaction of Antiphospholipid Antibodies with Endothelial Cells. In: Khamashta, M.A. (eds) Hughes Syndrome. Springer, London. https://doi.org/10.1007/1-84628-009-5_33

Download citation

  • DOI: https://doi.org/10.1007/1-84628-009-5_33

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-873-2

  • Online ISBN: 978-1-84628-009-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation